Effects of captopril in patients with chronic obstructive pulmonary disease and secondary pulmonary hypertension
- PMID: 3050941
- PMCID: PMC2428827
- DOI: 10.1136/pgmj.64.749.193
Effects of captopril in patients with chronic obstructive pulmonary disease and secondary pulmonary hypertension
Abstract
Ten patients with chronic obstructive pulmonary disease (COPD) with normal left ventricular function were given a single dose of captopril (0.25 mg/kg). Mean systemic arterial pressure, heart rate and coronary flow to the right ventricle were reduced significantly after captopril. In contrast captopril did not cause a significant fall in pulmonary arterial pressure or pulmonary vascular resistance. We conclude that captopril fails to produce haemodynamic benefits in such hypoxic patients and that angiotensin II is not playing a significant role in maintaining pulmonary vasoconstriction.
Similar articles
-
Acute effects of captopril in hypoxic pulmonary hypertension. Comparison with transient oxygen administration.Respiration. 1985;48(4):296-302. doi: 10.1159/000194843. Respiration. 1985. PMID: 3909277
-
[The effect of captopril on hemodynamics in patients of chronic obstructive pulmonary disease with pulmonary hypertension].Zhonghua Nei Ke Za Zhi. 1993 Aug;32(8):545-8. Zhonghua Nei Ke Za Zhi. 1993. PMID: 8269786 Chinese.
-
Influence of ACE inhibition on pulmonary haemodynamics and function in patients in whom beta-blockers are contraindicated.Postgrad Med J. 1986;62 Suppl 1:47-51. Postgrad Med J. 1986. PMID: 3022273
-
[Effects of captopril on hemodynamics, gas exchange and exercise capacity in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease].Arq Bras Cardiol. 1989 Feb;52(2):59-67. Arq Bras Cardiol. 1989. PMID: 2688602 Review. Portuguese.
-
Cardiovascular performance in chronic obstructive pulmonary diseases.Med Clin North Am. 1981 May;65(3):489-524. doi: 10.1016/s0025-7125(16)31511-5. Med Clin North Am. 1981. PMID: 7017301 Review. No abstract available.
Cited by
-
Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease.Respir Res. 2005 Aug 1;6(1):88. doi: 10.1186/1465-9921-6-88. Respir Res. 2005. PMID: 16060962 Free PMC article. Clinical Trial.
-
Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans.Thorax. 1995 Feb;50(2):183-5. doi: 10.1136/thx.50.2.183. Thorax. 1995. PMID: 7701460 Free PMC article. Clinical Trial.
-
Pulmonary hypertension associated with COPD.Int J Chron Obstruct Pulmon Dis. 2008;3(1):55-70. doi: 10.2147/copd.s1170. Int J Chron Obstruct Pulmon Dis. 2008. PMID: 18488429 Free PMC article. Review.
-
Comparative effects of angiotensin II on Doppler parameters of left and right heart systolic and diastolic blood flow.Br J Clin Pharmacol. 1994 Mar;37(3):273-8. doi: 10.1111/j.1365-2125.1994.tb04275.x. Br J Clin Pharmacol. 1994. PMID: 8198937 Free PMC article.
-
The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.Br J Clin Pharmacol. 1995 Jul;40(1):11-8. doi: 10.1111/j.1365-2125.1995.tb04528.x. Br J Clin Pharmacol. 1995. PMID: 8527262 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical